NovoCure (NVCR) Soars 5.3%: Is Further Upside Left in the Stock?

NovoCure (NVCR) shares soared 5.3% in the last trading session to close at $18. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 11.9% loss over the past four weeks.The sudden rise in the stock price can be attributed to the growing investors optimism related to the company’s efforts in the development and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, which are approved for the ...